Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade

Published:2019-02 Issue:2 Volume:152 Page:251-258
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Boland Julia L.,Zhou Qin,Martin Madhuri,Callahan Margaret K.,Konner Jason,O'Cearbhaill Roisin E.,Friedman Claire F.,Tew William,Makker Vicky,Grisham Rachel N.,Hensley Martee L.,Zecca Nicholas,Iasonos Alexia E.,Snyder Alexandra,Hyman David M.,Sabbatini Paul,Aghajanian Carol,Cadoo Karen A.,Zamarin Dmitriy^ORCID

Funder

Ovarian Cancer Research Foundation Liz Tilberis Award

Department of Defense

National Cancer Institute

Memorial Sloan-Kettering Cancer Center

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference37 articles.

1. The future of immune checkpoint therapy;Sharma;Science,2015

2. Immune checkpoint inhibition in ovarian cancer;Hamanishi;Int. Immunol.,2016

3. Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicine;Zamarin;Gynecol. Oncol.,2016

4. Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: interim results from the phase 2 KEYNOTE-100 study;Matulonis;J. Clin. Oncol.,2018

5. Molecular and biochemical aspects of the PD-1 checkpoint pathway;Boussiotis;N. Engl. J. Med.,2016

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of TIM-3 in ovarian cancer: the forsaken cop or a new noble;Frontiers in Immunology;2024-08-13

2. New Achievements from Molecular Biology and Treatment Options for Refractory/Relapsed Ovarian Cancer—A Systematic Review;Cancers;2023-11-10

3. Blood Plasma Small Non-Coding RNAs as Diagnostic Molecules for the Progesterone-Receptor-Negative Phenotype of Serous Ovarian Tumors;International Journal of Molecular Sciences;2023-07-30

4. Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery;International Journal of Molecular Sciences;2023-07-13

5. Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors;International Journal of Molecular Sciences;2023-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3